Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP578700.RAfTPzq1KqllI8pku-JDGkp2LJ1HU21pZjV_tgy9G-CrE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP578700.RAfTPzq1KqllI8pku-JDGkp2LJ1HU21pZjV_tgy9G-CrE130_assertion type Assertion NP578700.RAfTPzq1KqllI8pku-JDGkp2LJ1HU21pZjV_tgy9G-CrE130_head.
- NP578700.RAfTPzq1KqllI8pku-JDGkp2LJ1HU21pZjV_tgy9G-CrE130_assertion description "[Thus, MUC1 and c-Met could serve as potential therapeutic targets in HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP578700.RAfTPzq1KqllI8pku-JDGkp2LJ1HU21pZjV_tgy9G-CrE130_provenance.
- NP578700.RAfTPzq1KqllI8pku-JDGkp2LJ1HU21pZjV_tgy9G-CrE130_assertion evidence source_evidence_literature NP578700.RAfTPzq1KqllI8pku-JDGkp2LJ1HU21pZjV_tgy9G-CrE130_provenance.
- NP578700.RAfTPzq1KqllI8pku-JDGkp2LJ1HU21pZjV_tgy9G-CrE130_assertion SIO_000772 22962849 NP578700.RAfTPzq1KqllI8pku-JDGkp2LJ1HU21pZjV_tgy9G-CrE130_provenance.
- NP578700.RAfTPzq1KqllI8pku-JDGkp2LJ1HU21pZjV_tgy9G-CrE130_assertion wasDerivedFrom befree-20150227 NP578700.RAfTPzq1KqllI8pku-JDGkp2LJ1HU21pZjV_tgy9G-CrE130_provenance.
- NP578700.RAfTPzq1KqllI8pku-JDGkp2LJ1HU21pZjV_tgy9G-CrE130_assertion wasGeneratedBy ECO_0000203 NP578700.RAfTPzq1KqllI8pku-JDGkp2LJ1HU21pZjV_tgy9G-CrE130_provenance.